Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy

Anil H. Kadam(Proteogenomics Research Institute for Systems Medicine), Jan E. Schnitzer(Proteogenomics Research Institute for Systems Medicine)
bioRxiv (Cold Spring Harbor Laboratory)
September 15, 2022
10.1101/2022.09.12.507679
Cited by 3

Related Papers

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung
|Nature Biotechnology|2007|305
Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy
|PLoS ONE|2022|10
Insights into Disease Progression of Translational Preclinical Rat Model of Interstitial Pulmonary Fibrosis through Endpoint Analysis
|Cells|2024|10